Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Cue Biopharma, Inc. (CUE)
Sector: Healthcare; Industry: Biotechnology

Cue Biopharma, Inc., a biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. The company offers CUE-102, an onco-fetal viral antigen for cancers, including solid tumors and hematologic malignancies; CUE-103, an antigen; CUE-200 framework that includes CD80 and/or 4-1BBL to reactivate exhausted T cells and design to enhance antigen-specific T cell for the treatment of chronic infectious diseases; and CUE-300 framework to target various autoimmune diseases. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-16 Pienta Kenneth Chief Medical Officer Sell 13,439 $15.10 $202,894 Yes
2021-02-17 Pienta Kenneth Chief Medical Officer Sell 20,274 $15.13 $306,767 Yes
2021-01-20 Pienta Kenneth Chief Medical Officer Sell 2,720 $15.07 $40,980 Yes
2021-01-20 Pienta Kenneth Chief Medical Officer Buy 2,720 $15.07 $40,980 No
2020-11-24 Fletcher Aaron G.L. Director Buy 6,548 $12.64 $82,776 No
2020-09-30 Gray Cameron Director Buy 10,000 $15.15 $151,500 No
2020-08-05 Sandercock Colin SVP, General Counsel and Sec Sell 13,374 $20.00 $267,480 Yes
2020-08-05 Sandercock Colin SVP, General Counsel and Sec Sell 13,274 $20.00 $265,480 Yes
2020-08-05 Suri Anish President and CSO Sell 800 $20.01 $16,008 Yes
2020-08-04 Sandercock Colin SVP, General Counsel and Sec Sell 6,626 $20.00 $132,530 Yes
2020-08-04 Suri Anish President and CSO Sell 6,200 $20.02 $124,114 Yes
2020-06-24 Fletcher Aaron G.L. Director Buy 7,500 $24.88 $186,572 No
2019-06-10 Sandercock Colin SVP, General Counsel and Sec Buy 15,125 $7.90 $119,432 No
2019-12-31 MARLETT CHRISTOPHER A Director Sell 24,700 $16.28 $402,209 No
2019-12-26 MARLETT CHRISTOPHER A Director Sell 36,647 $17.20 $630,352 No
2019-12-19 MARLETT CHRISTOPHER A Director Sell 24,732 $15.94 $394,114 No
2019-06-21 PASSERI DANIEL R CEO and President Buy 1,377 $7.26 $9,997 No
2019-06-10 Sandercock Colin SVP, General Counsel and Sec Buy 16,938 $7.83 $132,658 No
2019-06-06 PASSERI DANIEL R CEO and President Buy 3,000 $6.90 $20,700 No
2018-12-24 DIGIANDOMENICO ANTHONY Director Buy 10,000 $4.81 $48,100 No
2018-12-31 MARLETT CHRISTOPHER A Director Buy 18,521 $4.64 $85,937 No
2018-12-28 DIGIANDOMENICO ANTHONY Director Buy 7,000 $4.62 $32,340 No
2018-12-27 DIGIANDOMENICO ANTHONY Director Buy 20,000 $4.77 $95,400 No
2018-12-26 MARLETT CHRISTOPHER A Director Buy 19,647 $4.29 $84,286 No
2018-12-21 Suri Anish Chief Scientific Officer Buy 2,000 $4.37 $8,740 No
2018-12-21 MARLETT CHRISTOPHER A Director Buy 17,200 $4.53 $77,916 No
2018-12-21 DIGIANDOMENICO ANTHONY Director Buy 10,000 $4.49 $44,900 No
2018-12-20 MARLETT CHRISTOPHER A Director Buy 9,438 $4.74 $44,736 No
2018-12-19 MARLETT CHRISTOPHER A Director Buy 400 $5.00 $2,000 No
2018-12-18 MARLETT CHRISTOPHER A Director Buy 3,664 $5.20 $19,053 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.